Total planned funding: $280,752,850
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $112,695,424 |
| Zambia | $38,761,375 |
| Mozambique | $20,800,879 |
| Vietnam | $16,748,851 |
| Kenya | $9,463,225 |
| South Africa | $8,632,249 |
| Haiti | $7,848,100 |
| Tanzania | $7,813,312 |
| Ghana | $6,982,500 |
| Botswana | $6,729,720 |
| Democratic Republic of the Congo | $5,991,445 |
| Côte d'Ivoire | $5,891,571 |
| Burundi | $5,189,907 |
| India | $4,650,000 |
| Rwanda | $4,308,060 |
| Papua New Guinea | $3,494,885 |
| Uganda | $3,123,638 |
| South Sudan | $2,868,967 |
| Indonesia | $2,330,000 |
| Angola | $2,250,000 |
| Namibia | $1,947,275 |
| Eswatini | $1,120,000 |
| Malawi | $612,000 |
| Lesotho | $250,000 |
| Dominican Republic | $200,000 |
| Ethiopia | $49,467 |
| Cambodia | $0 |
| Caribbean Region | $0 |
Organizational Types
| NGO | $280,752,850 |
Program Areas
| Care | $94,731,871 |
| Treatment | $66,784,163 |
| Prevention | $63,894,858 |
| Governance and Systems | $34,562,235 |
| Testing | $20,779,723 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $58,801,154 |
| HBHC: Care: Adult Care and Support | $42,229,686 |
| HKID: Care: Orphans and Vulnerable Children | $36,589,162 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $29,165,333 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $24,946,332 |
| HVCT: Testing: HIV Testing and Counseling | $20,779,723 |
| HLAB: Laboratory Infrastructure | $15,772,348 |
| OHSS: Health Systems Strengthening | $9,808,143 |
| HVTB: Care: TB/HIV | $9,469,605 |
| HVSI: Strategic Information | $8,981,744 |
| PDTX: Treatment: Pediatric Treatment | $7,983,009 |
| PDCS: Care: Pediatric Care and Support | $6,443,418 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,014,048 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,194,873 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,115,580 |
| HMIN: Biomedical Prevention: Injection Safety | $343,860 |
| HMBL: Biomedical Prevention: Blood Safety | $114,832 |
| HTXD: Treatment: ARV Drugs | $0 |